🔎 Trials Near Me

Utama › Karsinoma Urotelial (Sel Transisi) › Wilayah Columbia

Kajian klinikal Karsinoma Urotelial (Sel Transisi) di Wilayah Columbia

7 kajian untuk Karsinoma Urotelial (Sel Transisi) sedang mencari peserta di lokasi di Wilayah Columbia.

Bandar di Wilayah Columbia

Teks kajian rasmi (Bahasa Inggeris)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • MedStar Georgetown University Hospital, Washington D.C.
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT03866382

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

  • Sibley Memorial Hospital Pharmacy Department, Washington D.C.
  • Sibley Memorial Hospital, Washington D.C.
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07421700

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07277413

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • MedStar Washington Hospital Center, Washington D.C.
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07218380

A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma

  • Research Site, Washington D.C.
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07815665

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

  • Medstar Washington Hospital Center, Washington D.C.
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06774131

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

  • Medstar Washington Hospital Center, Washington D.C.
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jul 2026 · NCT04879329

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.